Joel Schlessinger, MD, Offers Revolutionary UltraShape® Treatment For Fat Cell Destruction

OMAHA, Neb., March 9, 2015 /PRNewswire/ -- Joel Schlessinger, MD, an Omaha based physician who is board-certified in dermatology and cosmetic surgery is pleased to announce the addition of UltraShape to his Skin Specialists, P.C. practice. Voted the Best Cosmetic Surgeon in Omaha for 15 years, Dr. Schlessinger is proud to bring the revolutionary non-invasive body shaping system to Nebraska, helping to change the way men and women achieve a shapelier physique.

The UltraShape System, developed by medical device leader Syneron Candela, is the only FDA-approved non-invasive body contouring system of its kind, offering measurable fat reduction to the abdominal area (an average of 2.5 inches) without the risks associated with other fat reduction procedures.

Unlike other body slimming technologies, UltraShape is completely painless. It also works more rapidly than any other fat destroying technology, safely delivering quick, visible results without heat, cold, bruising, incisions or anesthesia. Visible results may be seen as early as two weeks post first treatment. Since it is a non-invasive treatment, there is no downtime and it is safe for all skin types.

During treatment, pulsed focused ultrasound energy is used to precisely target subcutaneous fat, while keeping the surrounding tissue, vasculature, nerves and muscles intact. Unlike other body shaping technologies, UltraShape uses a pure mechanical effect to destroy fat cells without inducing thermal damage. This unique feature of the UltraShape technology results in a safe and comfortable treatment experience.

Thanks to UltraShape, men and women can finally have the flatter, firmer stomachs they've always wanted, without the agony endured to stay in shape. Instead of endless hours of sit-ups that may yield little results, men and women can now safely and comfortably eliminate belly fat in just three 45-minute sessions. Instead of sit-ups, "sit back," relax and eliminate stubborn belly fat that is resistant to diet and exercise with easy, painless ultrasound.

"We are excited to offer our patients UltraShape as there is nothing else on the market that is non-invasive and works faster," states Dr. Schlessinger. "UltraShape's patented technology allows us to precisely deliver ultrasound energy with extraordinary accuracy, allowing us to target and destroy fat cells immediately. Unlike traditional ultrasound technology, UltraShape distributes energy in pulses rather than in a single continuous delivery, which can be painful. It is a quick, safe and comfortable treatment experience without the pain, lumps, bumps or soreness associated with many other non-invasive fat reduction treatments." Treatments take less than an hour and patients can go right back to their normal activities without any disruption.

In the randomized, controlled clinical study of UltraShape, which was performed at three clinical sites in the US and one site outside of the US, a total of 150 subjects were treated and followed for up to four months. Ninety four percent of patients saw a measurable circumferential reduction with ninety percent of patients being satisfied with their treatment outcomes. This is one of the largest studies ever performed in the area of non-invasive aesthetics.

UltraShape is FDA cleared for fat cell destruction, and has been used in over 300,000 procedures worldwide with an excellent safety and efficacy profile.

To learn more about UltraShape or to request a consultation, call (402) 334-7546 or visit: http://www.lovelyskin.com/skin-specialists-omaha/dermatology/

JOEL SCHLESSINGER, MD
Skin Specialists, P.C.
2808 Oak View Drive, #100
Omaha, NE 68144
(402) 334-7546

To learn more about the UltraShape Ultimate Workout, visit: http://syneron-candela.com/na/product/ultrashape

About Syneron Candela
Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.  The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch, and has a wide portfolio of trusted, leading products including UltraShape, VelaShape, GentleLase, VBeam Perfecta, PicoWay and elōs Plus.

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Candela are located in Israel. Syneron Candela also has R&D and manufacturing operations in the U.S.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

For additional information, please visit http://www.syneron-candela.com.

SOURCE Syneron Candela

Related Links

http://www.syneron-candela.com